Anteris Technologies Global Corp.

Medical Instruments & Supplies • Healthcare • Toowong, QLD, United States • AVR (NGM)

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

61 7 3152 3200 Toowong Tower, Toowong, QLD 4066, Australia

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Anteris Technologies Issues 354,534 New Shares on Option Conversions - TipRanks

TipRanks • Dec 24

Anteris Technologies Global Corp. $AVR Shares Sold by L1 Capital Pty Ltd - MarketBeat

MarketBeat • Dec 15

Institutions own 23% of Anteris Technologies Global Corp. (ASX:AVR) shares but retail investors control 54% of the company - Yahoo Finance

Yahoo Finance • Aug 5

Anteris (NASDAQ: AVR) Posts 30-Day DurAVR THV Results in 100 Small Annulus Patients - Stock Titan

Stock Titan • Nov 17

Anteris Technologies Global completes $11.5 million common stock offering - Investing.com

Investing.com • Oct 27

Other Medical Instruments & Supplies Companies

View All →

Intuitive Surgical Inc.

$206.27B market cap

Becton Dickinson & Co.

WEST Pharmaceutical Services Inc.

$19.83B market cap

Frequently Asked Questions

Has Anteris Technologies Global Corp. had layoffs?

No layoff events have been recorded for Anteris Technologies Global Corp. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Anteris Technologies Global Corp. have?

Anteris Technologies Global Corp. has approximately 136 employees.

What industry is Anteris Technologies Global Corp. in?

Anteris Technologies Global Corp. operates in the Medical Instruments & Supplies industry, within the Healthcare sector.

Is Anteris Technologies Global Corp. a publicly traded company?

Yes, Anteris Technologies Global Corp. is publicly traded under the ticker symbol AVR on the NGM. The company has a market capitalization of approximately $0.23 billion.

Where is Anteris Technologies Global Corp. headquartered?

Anteris Technologies Global Corp. is headquartered in Toowong, QLD, United States at Toowong Tower, Toowong, QLD 4066, Australia.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.